IOVA

IOVA Cost of Revenue

$167.68MTTM · USD

Period ending:

IOVA FY Cost of RevenueUSD
IOVA FY Cost of Revenue2008-12-31: $0.002009-12-31: $1.33K2010-12-31: $0.002011-12-31: $19.30M2012-12-31: $6.48M2013-12-31: $4.66M2014-12-31: $88.22K2015-12-31: $999.00K2016-12-31: $978.00K2017-12-31: $952.00K2018-12-31: $956.00K2019-12-31: $8.12M2020-12-31: $0.002021-12-31: $0.002022-12-31: $0.002023-12-31: $10.76M2024-12-31: $124.00M2025-12-31: $173.18M$173.18M$0.00
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

IOVA cost of revenue history

Direct costs attributable to producing goods sold. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Iovance Biotherapeutics Inc Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
173,184,000
123,995,000
10,755,000
0
0
0
8,123,000
956,000
952,000
978,000
999,000
88,221
4,655,000
6,477,000
19,303,000
0
1,332
0

Compare cost of revenue

All IOVA financial metrics · IOVA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.